Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.
UCLH clinicians and researchers have launched a new ‘tele-otology’ service – the first of its kind in the UK that allows ENT surgeons to assess patients’ hearing and ear problems remotely and shorten treatment pathways.
UCL and UCLH researchers have published the first health economic model able to identify cost-effective innovative hearing loss treatments that can be adopted into hearing care.
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
UCL researchers have discovered how sleep is regulated differently in babies compared to adults.
UCLH Biomedical Research Centre supported Consultant Infectious Diseases Physician Professor Sir Alimuddin (Ali) Zumla has been awarded the 2020 Mahathir Science Award, the most prestigious international science award presented in recognition for the best scientific work in solving priority health problems in the tropics.
A team at UCLH, UCL and Mercedes-AMG High Performance Powertrains who developed a Continuous Positive Airway Pressure (CPAP) breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.
A cancer drug trialled for the first time in the world at the UCLH Clinical Research Facility (CRF) has been approved for use in patients in the United States.
Researchers from UCLH, UCL and the University of East Anglia have highlighted the need to identify, test and isolate healthcare workers who experience a new loss of taste or smell (anosmia).
New therapies in development and simpler methods of diagnosis offer hope for dementia patients of all ages, says Professor Nick Fox of UCL and UCLH.
Scientists at a new UCL centre will use tools such as machine learning to analyse intensive care data from two London hospitals to find clues that will improve the care of critically ill adults and babies.
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
UCLH and UCL researchers are working with Microsoft to see if chest imaging data can identify better who should shield in potential future COVID-19 outbreaks.
Researchers have highlighted the importance of routinely screening healthcare staff for the SARS-CoV-2 virus after finding a high proportion of front-facing staff had the virus during the peak of the pandemic.
Could dogs offer quick and effective diagnosis of Covid-19?